In summary, our data suggested that Ct-HBx downregulated the expression of TXNIP by transactivation through the transcription repressor NFATC2, then TXNIP exerted its tumor-suppressing function in HBV-induced HCC by negative regulating glycolytic metabolism (Fig. 7D). Here, TXNIP is linked to hepatocellular carcinoma.